SCHEMBL6602252

SCHEMBL6602252

COc1cc(C2=NN(C(=O)c3ccc(NC(=O)c4ccccn4)cc3)CCC2)ccc1S(C)(=O)=O

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.47
POLB P06746 1/20 0.47
GRM4 Q14833 7/20 0.47
AURKB Q96GD4 1/20 0.47
SMN1; SMN2 Q16637 4/20 0.44
NPC1 O15118 3/20 0.44
RAB9A P51151 2/20 0.44
KDM4E B2RXH2 1/20 0.44
PGR P06401 4/20 0.43
MAPT P10636 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
LMNA P02545 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
CFTR P13569 1/20 0.42
PKM P14618 1/20 0.42
GAA P10253 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6600023 0.92 ALDH1A1 (0.46) ALDH1A1POLBSMN1; SMN2PGRMAPT
SCHEMBL6603519 0.91 MEN1 (0.45) ALDH1A1POLBGRM4SMN1; SMN2NPC1
SCHEMBL6601572 0.90 NPC1 (0.56) ALDH1A1POLBGRM4AURKBSMN1; SMN2
SCHEMBL6603562 0.90 ALDH1A1 (0.42) ALDH1A1POLBGRM4SMN1; SMN2PGR
SCHEMBL6601093 0.88 ALDH1A1 (0.45) ALDH1A1POLBSMN1; SMN2KDM4EPGR
SCHEMBL6606987 0.88 PGR (0.43) ALDH1A1POLBSMN1; SMN2PGRMAPT
SCHEMBL6605929 0.87 ALDH1A1 (0.48) ALDH1A1POLBSMN1; SMN2PGRMAPT
SCHEMBL6602474 0.87 ALDH1A1 (0.48) ALDH1A1POLBSMN1; SMN2PGRMAPT
SCHEMBL146153 0.87 ABCG2 (0.45) ALDH1A1POLBSMN1; SMN2NPC1RAB9A
SCHEMBL6600779 0.86 NPC1 (0.49) ALDH1A1POLBGRM4AURKBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0922036-B1 ARYLALKANOYL PYRIDAZINES MERCK PATENT GMBH (DE) 2004-03-24 EP disclosed
US-6479494-B1 THEY INHIBIT SELECTIVELY PHOSPHODIESTERASE IV, WHICH CAUSES AN INCREASE OF THE INTRACELLULAR CAMP LEVEL AS CAMP INHIBITS BONE DECREASING CELLS AND STIMULATES BONE INCREASING CELLS FOR TREATMENT OF OSTEOPOROSIS MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) 2002-11-12 US disclosed
US-6107295-A Arylalkanoyl pyridazines MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2000-08-22 US disclosed